{"id":"https://openalex.org/W2139196151","doi":"https://doi.org/10.1021/ci6005504","title":"Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data","display_name":"Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data","alternate_titles":[],"publication_year":2007,"publication_date":"2007-07-01","ids":{"openalex":"https://openalex.org/W2139196151","doi":"https://doi.org/10.1021/ci6005504","mag":"2139196151","pmid":"https://pubmed.ncbi.nlm.nih.gov/17608469"},"language":"en","primary_location":{"id":"doi:10.1021/ci6005504","doi":"https://doi.org/10.1021/ci6005504","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ci6005504","pdf_url":null,"source":{"id":"https://openalex.org/S167262187","display_name":"Journal of Chemical Information and Modeling","issn_l":"1549-9596","issn":["1549-9596","1549-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemical Information and Modeling","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139196151"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083450649","display_name":"Thomas J. Crisman","orcid":"https://orcid.org/0000-0001-6235-8110","observed_orcids":["https://orcid.org/0000-0001-6235-8110"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Thomas J. Crisman","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067080424","display_name":"Christian N. Parker","orcid":"https://orcid.org/0000-0002-1355-6644","observed_orcids":["https://orcid.org/0000-0002-1355-6644"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christian N. Parker","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009211876","display_name":"Jeremy L. Jenkins","orcid":"https://orcid.org/0000-0001-9795-0771","observed_orcids":["https://orcid.org/0000-0001-9795-0771"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jeremy L. Jenkins","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048611593","display_name":"Josef Scheiber","orcid":"https://orcid.org/0000-0001-6427-480X","observed_orcids":["https://orcid.org/0000-0001-6427-480X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Josef Scheiber","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074904067","display_name":"Mathis Thoma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mathis Thoma","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zhao Bin Kang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Zhao Bin Kang","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009041563","display_name":"Richard Kim","orcid":"https://orcid.org/0000-0002-8709-5270","observed_orcids":["https://orcid.org/0000-0002-8709-5270"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Richard Kim","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026643759","display_name":"Andreas Bender","orcid":"https://orcid.org/0000-0002-6683-7546","observed_orcids":["https://orcid.org/0000-0002-6683-7546"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andreas Bender","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069293853","display_name":"James H. Nettles","orcid":"https://orcid.org/0000-0002-5683-8481","observed_orcids":["https://orcid.org/0000-0002-5683-8481"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"James H. Nettles","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102842893","display_name":"John W. Davies","orcid":"https://orcid.org/0000-0002-4847-1587","observed_orcids":["https://orcid.org/0000-0002-4847-1587"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"John W. Davies","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110421667","display_name":"Meir Glick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Meir Glick","raw_affiliation_strings":["Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Discovery Center, Novartis Institutes for Biomedical Research Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, and Lead Discovery Center, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.1118,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.96066746,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"47","issue":"4","first_page":"1319","last_page":"1327"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/false-positive-results","display_name":"false positives","score":0.9639999866485596},{"id":"https://openalex.org/keywords/reporter-gene-assay","display_name":"reporter gene assay","score":0.9620000123977661},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.6819999814033508},{"id":"https://openalex.org/keywords/hit-prioritization","display_name":"hit prioritization","score":0.8330000042915344},{"id":"https://openalex.org/keywords/chemogenomics","display_name":"chemogenomics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/in-silico-target-prediction","display_name":"in silico target prediction","score":0.8830000162124634},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.7379999756813049},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.9269999861717224},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8220000267028809},{"id":"https://openalex.org/keywords/cell-differentiation","display_name":"cell differentiation","score":0.7960000038146973},{"id":"https://openalex.org/keywords/kinases","display_name":"kinases","score":0.8450000286102295},{"id":"https://openalex.org/keywords/topoisomerases","display_name":"topoisomerases","score":0.9980000257492065},{"id":"https://openalex.org/keywords/protein-phosphatase","display_name":"protein phosphatase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C64869954","wikidata":"https://www.wikidata.org/wiki/Q1859747","display_name":"False positive paradox","level":2,"score":0.9272506237030029},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8069405555725098},{"id":"https://openalex.org/C2777615720","wikidata":"https://www.wikidata.org/wiki/Q11888847","display_name":"Prioritization","level":2,"score":0.6538335084915161},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6050519943237305},{"id":"https://openalex.org/C2989486834","wikidata":"https://www.wikidata.org/wiki/Q3808900","display_name":"True positive rate","level":2,"score":0.5671442747116089},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4944875240325928},{"id":"https://openalex.org/C112789634","wikidata":"https://www.wikidata.org/wiki/Q18207010","display_name":"False positives and false negatives","level":3,"score":0.47355523705482483},{"id":"https://openalex.org/C95922358","wikidata":"https://www.wikidata.org/wiki/Q5432725","display_name":"False positive rate","level":2,"score":0.44706398248672485},{"id":"https://openalex.org/C2779057010","wikidata":"https://www.wikidata.org/wiki/Q2963679","display_name":"Chemical library","level":3,"score":0.4451947808265686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3265524208545685},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.3212757110595703},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.301327109336853},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.18516314029693604},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.16422265768051147},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12554827332496643},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.07719939947128296},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005189","descriptor_name":"False Positive Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017930","descriptor_name":"Genes, Reporter","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023281","descriptor_name":"Genomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/ci6005504","doi":"https://doi.org/10.1021/ci6005504","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ci6005504","pdf_url":null,"source":{"id":"https://openalex.org/S167262187","display_name":"Journal of Chemical Information and Modeling","issn_l":"1549-9596","issn":["1549-9596","1549-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemical Information and Modeling","raw_type":"journal-article"},{"id":"pmid:17608469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17608469","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chemical information and modeling","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1964504843","https://openalex.org/W1965326858","https://openalex.org/W1975324295","https://openalex.org/W1975574634","https://openalex.org/W1994360534","https://openalex.org/W2004716554","https://openalex.org/W2015066175","https://openalex.org/W2029112828","https://openalex.org/W2030297745","https://openalex.org/W2033495141","https://openalex.org/W2043014029","https://openalex.org/W2045987477","https://openalex.org/W2052960342","https://openalex.org/W2060531713","https://openalex.org/W2060581674","https://openalex.org/W2063379654","https://openalex.org/W2064260436","https://openalex.org/W2082577020","https://openalex.org/W2085590224","https://openalex.org/W2095178327","https://openalex.org/W2099536767","https://openalex.org/W2112912103","https://openalex.org/W2127287358","https://openalex.org/W2131272506","https://openalex.org/W2135945518","https://openalex.org/W2138778824","https://openalex.org/W2154183412","https://openalex.org/W2166994948","https://openalex.org/W2167292136","https://openalex.org/W2205755822","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W3189042957","https://openalex.org/W6931325959","https://openalex.org/W2781072068","https://openalex.org/W4386515108","https://openalex.org/W4398761925","https://openalex.org/W7164481134","https://openalex.org/W2306604335","https://openalex.org/W2145803535","https://openalex.org/W3003076402","https://openalex.org/W2063365408"],"abstract_inverted_index":{"High":[0],"throughput":[1],"screening":[2],"(HTS)":[3],"data":[4],"is":[5],"often":[6],"noisy,":[7],"containing":[8],"both":[9],"false":[10,32,94],"positives":[11,33],"and":[12,17,27,155,161,205,220],"negatives.":[13],"Thus,":[14],"careful":[15],"triaging":[16],"prioritization":[18],"of":[19,38,52,75,210],"the":[20,36,50,100,117,126,131,147,178,208],"primary":[21],"hit":[22,193,199],"list":[23],"can":[24],"save":[25],"time":[26],"money":[28],"by":[29,177],"identifying":[30],"potential":[31,93],"before":[34],"incurring":[35],"expense":[37],"followup.":[39],"Of":[40],"particular":[41],"concern":[42],"are":[43],"cell-based":[44],"reporter":[45],"gene":[46],"assays":[47],"(RGAs)":[48],"where":[49],"number":[51],"hits":[53],"may":[54],"be":[55,59,137,181],"prohibitively":[56],"high":[57],"to":[58,91,112,136,153,180,196],"scrutinized":[60],"manually":[61],"for":[62,116,130],"weeding":[63],"out":[64],"erroneous":[65],"data.":[66],"Based":[67],"on":[68],"statistical":[69],"models":[70,86,212],"built":[71],"from":[72],"chemical":[73,105,218],"structures":[74],"650":[76],"000":[77],"compounds":[78,175],"tested":[79,170],"in":[80,108,184],"RGAs,":[81],"we":[82,97],"created":[83],"\"frequent":[84],"hitter\"":[85],"that":[87,125],"make":[88],"it":[89,206],"possible":[90],"prioritize":[92],"positives.":[95],"Furthermore,":[96],"followed":[98],"up":[99],"frequent":[101,132,166],"hitter":[102,167],"evaluation":[103],"with":[104,139],"structure":[106,219],"based":[107],"silico":[109],"target":[110],"predictions":[111],"hypothesize":[113],"a":[114,191,197],"mechanism":[115],"observed":[118,124],"\"off":[119],"target\"":[120],"response.":[121],"It":[122],"was":[123,169,188],"predicted":[127,150,176],"cellular":[128],"targets":[129,151],"hitters":[133],"were":[134],"known":[135],"associated":[138],"undesirable":[140],"effects":[141],"such":[142],"as":[143,201,203],"cytotoxicity.":[144],"More":[145],"specifically,":[146],"most":[148],"frequently":[149],"relate":[152],"apoptosis":[154],"cell":[156],"differentiation,":[157],"including":[158],"kinases,":[159],"topoisomerases,":[160],"protein":[162],"phosphatases.":[163],"The":[164],"mechanism-based":[165],"hypothesis":[168],"using":[171],"160":[172],"additional":[173],"druglike":[174],"model":[179],"nonspecific":[182],"actives":[183],"RGAs.":[185],"This":[186],"validation":[187],"successful":[189],"(showing":[190],"50%":[192],"rate":[194,200],"compared":[195],"normal":[198],"low":[202],"2%),":[204],"demonstrates":[207],"power":[209],"computational":[211],"toward":[213],"understanding":[214],"complex":[215],"relations":[216],"between":[217],"biological":[221],"function.":[222]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139196151","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
